Your Article Summary
See Latest ArticlesContinuous Positive Airway Pressure Therapy Improves Hypoadiponectinemia in Severe Obese Men with Obstructive Sleep Apnea without Changes in Insulin Resistance
Metabolic Syndrome and Related Disorders, 07/01/09
Carneiro G et al. - NCPAP therapy reverses hypoadiponectinemia levels present in obese men with OSA, probably through reductions in hypoxia and inflammation activity.
Related Articles
Insulin resistance in hyperthyroidism: the role of IL-6 and TNFalpha
European Journal of Endocrinology, 11/04/09
Relevance Score: 70%
Does skeletal muscle oxidative stress initiate insulin resistance in genetically predisposed individuals
Trends in Endocrinology and Metabolism, 11/03/09
Relevance Score: 70%
Evolution, body composition, insulin receptor competition, and insulin resistance
Preventive Medicine, 11/02/09
Relevance Score: 70%
Age-Associated Increase in Abdominal Obesity and Insulin Resistance, and Usefulness of AHA/NHLBI Definition of Metabolic Syndrome for Predicting Cardiovascular Disease in Japanese Elderly with Type 2 Diabetes Mellitus
Gerontology, 10/19/09
Relevance Score: 70%
Insulin Resistance, beta-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population: The Insulin Resistance Atherosclerosis Study (IRAS)
Diabetes Care, 10/14/09
Relevance Score: 70%
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence of Metabolic Syndrome in a Rural Community in Nigeria
Metabolic Syndrome and Related Disorders, 12/08/09
Insulin Resistance and Metabolic Syndrome in the Pediatric Population
Metabolic Syndrome and Related Disorders, 12/08/09
Effect of Alginate on Satiation, Appetite, Gastric Function, and Selected Gut Satiety Hormones in Overweight and Obesity
Obesity, 12/08/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09